Article

Poniard Appoints Chief Medical Officer

Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer.

Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer. Glassberg, who served as director of the company until June 2006, joined Poniard after working at the University of California, San Francisco’s (UCSF, www.ucsf.edu) Comprehensive Cancer Center, where he served as associate director of clinical care and director of general oncology.

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.